- Home
- NRSN vs FLGC Comparison
NRSN vs FLGC Comparison
Compare NRSN & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- FLGC
- Stock Information
- Founded
- NRSN 2017
- FLGC 2019
- Country
- NRSN Israel
- FLGC United States
- Employees
- NRSN N/A
- FLGC N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- NRSN Health Care
- FLGC Health Care
- Exchange
- NRSN Nasdaq
- FLGC Nasdaq
- Market Cap
- NRSN 17.8M
- FLGC 17.3M
- IPO Year
- NRSN 2021
- FLGC 2021
- Fundamental
- Price
- NRSN $1.09
- FLGC $0.96
- Analyst Decision
- NRSN Hold
- FLGC Strong Buy
- Analyst Count
- NRSN 1
- FLGC 4
- Target Price
- NRSN N/A
- FLGC $5.67
- AVG Volume (30 Days)
- NRSN 374.5K
- FLGC 336.2K
- Earning Date
- NRSN 12-18-2024
- FLGC 11-13-2024
- Dividend Yield
- NRSN N/A
- FLGC N/A
- EPS Growth
- NRSN N/A
- FLGC N/A
- EPS
- NRSN N/A
- FLGC N/A
- Revenue
- NRSN N/A
- FLGC $64,154,000.00
- Revenue This Year
- NRSN N/A
- FLGC N/A
- Revenue Next Year
- NRSN N/A
- FLGC $8.94
- P/E Ratio
- NRSN N/A
- FLGC N/A
- Revenue Growth
- NRSN N/A
- FLGC N/A
- 52 Week Low
- NRSN $0.51
- FLGC $0.75
- 52 Week High
- NRSN $2.33
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- NRSN 47.35
- FLGC 38.08
- Support Level
- NRSN $1.01
- FLGC $0.90
- Resistance Level
- NRSN $1.13
- FLGC $1.17
- Average True Range (ATR)
- NRSN 0.09
- FLGC 0.08
- MACD
- NRSN -0.01
- FLGC 0.00
- Stochastic Oscillator
- NRSN 27.27
- FLGC 25.05
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.